Transforming Obesity Care with GLP-1 and Digital Health

Created using ChatSlide

This presentation explores obesity as a chronic disease, highlighting biological challenges and limitations of traditional methods. It introduces GLP-1 drugs and their role in appetite regulation, gut motility, and sustained weight loss. We analyze the global market potential, projected to reach $100B by 2030, with a special focus on India. Dr. Motabhai's integrated obesity management system combines innovative medications with structured care for long-term outcomes. The business model...